About this trial
The number of hip, knee, shoulder, ankle and elbow prostheses, as well as the amount of economic resources dedicated to this type of intervention, are constantly growing. Prosthetic interventions are not always effective, in some cases they have shown poor results and a high incidence of infections. For rare diseases such as haemophilia and haemophilic arthropathy, collecting retrospective and prospective data is the first step in estimating prevalence or incidence and the opportunity to stimulate future research and to facilitate recruitment into studies. Such studies may present data on the demographic aspects of patients to describe the population receiving the procedures, the patterns of use over time, the risks of review and the outcomes reported by patients. This retrospective/prospective study aims to describe and analyze the risk factors associated with the patient, the surgical technique and obtain outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adult patients with MEC (in particular Haemophilia A and Haemophilia B, with and without inhibitor, Von Willebrand's disease (VWD), other coagulation factor deficits)
they are undergoing prosthetic surgery
they have signed informed consent.
Disqualifiers
Subjects < 18 years old;
Subjects with acquired haemorrhagic disorders
Lack of signed informed consent.
Trial population
adult patients with MEC
Trial design
Cohort
Other
Treatments tested in this trial
Prosthetic Surgery
Procedure/SurgeryProsthetic Surgery in Patients with Congenital Coagulation Diseases
Treatment groups
Trial outcomes
Primary outcomes
Primary and secondary prosthesis removal rate in adult's patient population with MAC
Secondary outcomes
Peri- and post-operative complications
Sponsors and contacts
Click on the lead sponsor to view all of their trials.